Log In
Print
BCIQ
Print
Print this Print this
 

Xience V (Promus)

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionEverolimus-eluting coronary stent system utilizing a durable polymer
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today